Landscape of existing investments and priorities Lisa Hedman Department of Essential Medicines and Health Products Policy Access and Use Interagency Supply Group ISG members undertook an informal landscaping exercise ID: 431102
Download Presentation The PPT/PDF document "Procurement and Supply Management" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Procurement and Supply Management
Landscape of existing
investments and priorities
Lisa Hedman
Department of Essential Medicines and Health Products
Policy Access and UseSlide2
Interagency Supply Group (ISG) members*
†
undertook an informal landscaping exercise. ISG polled current participants on their investments in Procurement and Supply Chain Management (PSM).What program areas?What technical PSM areas?If possible, how much funding?*WHO, UN Commission on Life Saving Commodities, and Reproductive Maternal Newborn and Child Health Trust (RMNCH) (Hedman, L, Bijleveld, P)†RMNCH Trust includes investments from Norway, DFID and others
Landscape of investmentsSlide3
Rationale
Global medicines market estimated to increase:
US$235 billion, reaching up to $1.2 trillion by 2017Increasing role of external funding in country medicines budgets: 15% average increase from 2000 – 2012
1-The
Global Use of Medicines: Outlook through 2017. Report by the IMS Institute for Healthcare Informatics.
2-World
Health Organization Global Health Expenditures database
http://apps.who.int/nha/databaseSlide4
Rationale
Proliferation of performance
indicators Few relate to performance, management or connect to systems such as results based financingPromising technologies, innovations are fragmented in use, unclear if scale up would be possibleSMS-for-Life, C-stock, Rolling Warehouse, Topping upSlide5
Investments are strong, but coordination could be betterSlide6
Photo: Lisa Berg Hedman, WHO
Well-resourced GF procurement
reported a 36% OTIF rate.
l
OTIF = on time in
fullSlide7
Interagency Supply Group
Overall
VisionThe global development partners will collaborate in support of countries’ efforts to have sustainable access to quality essential health commodities and supplies at the right time, in the right place and at lowest possible cost for those who need them, through cost-effective and efficient procurement and supply systems.Current participants: WHO, UNICEF, UNFPA, GAVI, RMNCH Trust, World Bank, Global Fund, multiple implementing partnersSlide8
Interagency Supply Group
Recently hosted by the Interagency Pharmaceutical Coordination (IPC) and drafted a common vision
Undertook an informal landscaping of PSM investmentsPriority global activities identified by the ISGRevisions of PSM KPIsIncentives to engage in coordination down to operational levelsInformation sharing e.g., assessmentsIn depth analysis of systems options for the futureSupporting country PSM strategic plansSlide9
Investment by responding agenciesSlide10
Investment by program typeSlide11
Investment by technical areaSlide12
Alignment with country priorities
(highlights from select GF PSM concept notes)Slide13
Global initiatives and opportunities
Country PSM strategic plans are submitted within the new GF new funding model, so opportunities for coordination are high.
World Bank and Gates launching knowledge initiatives on future models to accommodate growth.Interagency Supply Group, RMNCH Trust are committed to harmonizing with a view of increasing the impact of investments, country efforts. Slide14
Investment by
agency and technical areaSlide15
Conclusion
Growth in
demand for medicines may outpace existing investment approaches.Serious consideration of future PSM systems and models is urgent. Investments on the part of countries is considerable, but could be better quantified.Efforts to harmonize systems need to be both strategic, operational, and require incentives.Slide16
As Secretariat to the Interagency Pharmaceutical Coordination group, offered to host the ISG long term.
Expert meeting on KPIs scheduled for 4
th Q 2014.Continued mapping of activities, moving into country priorities.Supporting the steering committees of the World Bank knowledge project.Leveraging work on the UN Commission on Life Saving commodities to raise awareness of PSM needs.WHO activitiesSlide17
In alignment with behavior #4 on procurement.
Long term coordination plans in countries need support.
IHP+ as a key partner in ISG and coordination activities. IHP+ potential roles